Bakkt Holdings
BKKT
Bit Origin
BTOG
Mawson Infrastructure
MIGI
IREN Ltd
IREN
Riot Platforms
RIOT
US Stock MarketDetailed Quotes
MNMD Mind Medicine
- 6.6505
- -0.0495-0.74%
Trading Mar 20 10:02 ET
501.24MMarket Cap-4.32P/E (TTM)
6.7000High6.5830Low57.15KVolume6.6200Open6.7000Pre Close379.13KTurnover0.08%Turnover RatioLossP/E (Static)75.37MShares12.220052wk High2.08P/B466.81MFloat Cap5.032952wk Low--Dividend TTM70.19MShs Float86.5500Historical High--Div YieldTTM1.75%Amplitude2.1200Historical Low6.6330Avg Price1Lot Size
Mind Medicine News
Baird Maintains Mind Medicine(MNMD.US) With Buy Rating, Cuts Target Price to $16
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
Mind Medicine Price Target Cut to $16.00/Share From $27.00 by Baird
Mind Medicine Is Maintained at Outperform by Baird
Baird Maintains Outperform on Mind Medicine, Lowers Price Target to $16
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mind Medicine (MNMD), SurModics (SRDX) and Enhabit, Inc (EHAB)
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
Chardan Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
Analysts Offer Insights on Healthcare Companies: Mind Medicine (MNMD), Elevation Oncology (ELEV) and Xeris Pharmaceuticals (XERS)
Mind Medicine Analyst Ratings
Mind Medicine's Promising Future: Buy Rating Backed by Strong Phase 3 Prospects and Financial Position
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Mind Medicine Analyst Ratings
Optimistic Buy Rating for Mind Medicine's MM120 Amid Promising Phase 3 Progress and Strong Phase 2b Results
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Evercore Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $23
Mind Medicine Analyst Ratings
Evercore ISI Group Initiates Coverage On Mind Medicine With Outperform Rating, Announces Price Target of $23
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.